{"id":"0769c607-bd70-42e1-b9c8-2d310064fa23","kind":"news","code":"0769c607-bd70-42e1-b9c8-2d310064fa23","name":"Encoded Therapeutics Raises $275M Series F for Gene Therapies","nameBasis":"translated-title","summary":"On September 9, 2026, per Encoded Therapeutics, gene therapy company for neurological disorders closed a $275M Series F co-led by GV and an unnamed healthcare fund, with ARCH, Braidwell, Illumina Ventures and SoftBank Vision Fund 2. The company was co-founded by Kartik Ramamoorthi and Stephanie Tagliatela.","description":"","country":null,"category":null,"originalName":"Encoded Therapeutics完成2.75亿美元F轮融资，推进基因疗法","eventDate":"2026-09-09T00:00:00.000Z","website":"https://encoded.com/encoded-therapeutics-raises-275-million-in-series-f-financing-to-advance-etx101-","sourceUpdatedAt":"2026-10-16T18:48:17.342Z","englishUpdatedAt":"2026-10-20T18:21:32.462Z","reviewedAt":"2026-10-20T18:21:32.462Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"d7397a1d0048b141d7f2f1c00be322b91139d13a2cbe8cc280786e5345896c29","companyId":"e03ba739-db71-48b6-a699-00cfdc475b5f","foundedYear":null,"logoUrl":null,"originalText":"2026年9月9日，据Encoded Therapeutics官网，神经疾病基因疗法公司正式完成2.75亿美元F轮融资，由GV及另一家未具名医疗健康基金共同领投，ARCH、Braidwell、Illumina Ventures、SoftBank Vision Fund 2等参与。公司由Kartik Ramamoorthi和Stephanie Tagliatela共同创立。","sources":[{"url":"https://encoded.com/encoded-therapeutics-raises-275-million-in-series-f-financing-to-advance-etx101-","publishedOn":"2026-09-09T00:00:00.000Z"}],"related":[{"id":"0d7b132c-9f7f-4cb7-af67-27dfe1d59199","kind":"institutions","code":"UB-I2761","name":"ARCH","nameBasis":"original-brand","summary":"ARCH, a venture capital firm focused on technology investments.","description":"ARCH, a venture capital firm focused on technology investments.","country":"United States","category":null,"originalName":"ARCH","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.747Z","englishUpdatedAt":"2026-10-20T18:26:49.254Z","reviewedAt":"2026-10-20T18:26:49.254Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"baa62662f3f1a13197198fdfa135dc186a7f8adf4230c9f92732673b6dd1626c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/arch"},{"id":"851b5196-d17d-49a8-86c3-14a0de5ce635","kind":"institutions","code":"UB-I2715","name":"Braidwell","nameBasis":"original-brand","summary":"Braidwell, a venture capital firm focused on medical investments.","description":"Braidwell, a venture capital firm focused on medical investments.","country":"United States","category":null,"originalName":"Braidwell","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-19T01:00:15.340Z","englishUpdatedAt":"2026-10-20T18:26:56.917Z","reviewedAt":"2026-10-20T18:26:56.917Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"0b1112314920c79a24a462918ff0f9c2eb5c6513f5fa3d186ada29b52cfc218a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/braidwell"},{"id":"e03ba739-db71-48b6-a699-00cfdc475b5f","kind":"companies","code":"UB-C9396","name":"Encoded Therapeutics","nameBasis":"source-english","summary":"","description":"","country":null,"category":null,"originalName":"Encoded Therapeutics","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-12T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:36.865Z","reviewedAt":"2026-10-20T18:26:36.865Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"f032367c8bcc247a3b94dd73fb97c5e40b62cbba1b040de557efc689bb7ffd0a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/encoded-therapeutics"},{"id":"e3b56de9-fe2e-48d1-a458-4d066c8c6b05","kind":"institutions","code":"UB-I1521","name":"Illumina Ventures","nameBasis":"original-brand","summary":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","description":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","country":"United States","category":null,"originalName":"Illumina Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:16.444Z","englishUpdatedAt":"2026-10-20T18:27:03.932Z","reviewedAt":"2026-10-20T18:27:03.932Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"42c6811f542a7c7bd5b90e2c7d9d4713fdd7a03bf5996281a1c14cdf5904fa25","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/illumina-ventures"},{"id":"71b33918-03e7-4abe-821b-a87091b5543c","kind":"institutions","code":"UB-I184","name":"Ruanyinyuanjing Fund Phase Two","nameBasis":"transliterated","summary":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","description":"SoftBank Group's Vision Fund II, a large global technology growth industry fund.","country":"Japan","category":null,"originalName":"软银愿景基金二期","eventDate":null,"website":"https://visionfund.com/","sourceUpdatedAt":"2026-10-18T22:00:13.736Z","englishUpdatedAt":"2026-10-20T18:26:56.700Z","reviewedAt":"2026-10-20T18:26:56.700Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"8bff6e030450f3ca091d956b27cbd239db2c2663f000a3921ae7df89c4c91e5f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ruanyinyuanjing-fund-phase-two"}],"path":"/news/0769c607-bd70-42e1-b9c8-2d310064fa23","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Encoded Therapeutics","path":"/companies/encoded-therapeutics"}},"canonical":"https://uniquebase.ai/news/0769c607-bd70-42e1-b9c8-2d310064fa23"}